The obligation to provide antiretroviral treatment in HIV prevention trials.
暂无分享,去创建一个
[1] A. Forbes. Moving Toward Assured Access to Treatment in Microbicide Trials , 2006, PLoS medicine.
[2] S. Benatar,et al. Moral Imagination : The Missing Component in Global Health Loading metrics , 2016 .
[3] S. Benatar,et al. Global Health Challenges: The Need for an Expanded Discourse on Bioethics , 2005, PLoS medicine.
[4] D. Wassenaar,et al. Provision of HIV treatment in HIV preventive vaccine trials: a developing country perspective. , 2005, Social science & medicine.
[5] S. R. Benatar,et al. HIV prevention research and global inequality: steps towards improved standards of care* , 2005, Journal of Medical Ethics.
[6] S. Knobler,et al. Scaling up treatment for the global AIDS pandemic : challenges and opportunities , 2005 .
[7] Treating people with intercurrent infection in HIV prevention trials Report from a WHO/UNAIDS consultation, Geneva 17–18th July 2003 , 2004, AIDS.
[8] J. Singh. Standards of care in the antiretroviral rollout world , 2004, The Lancet.
[9] J. Ananworanich,et al. Creation of a drug fund for post-clinical trial access to antiretrovirals , 2004, The Lancet.
[10] T. Tucker,et al. Not if but how? Caring for HIV-1 vaccine trial participants in South Africa , 2003, The Lancet.
[11] S. Berkley. Thorny issues in the ethics of AIDS vaccine trials , 2003, The Lancet.
[12] S. Eckstein. The ethics of research related to healthcare in developing countries , 2003 .